|
HSPA13 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.370100E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.296190E-02 |
| Normal-vs-Stage2 |
3.725600E-02 |
| Normal-vs-Stage3 |
1.23220000003421E-06 |
| Normal-vs-Stage4 |
4.16569999994731E-06 |
| Stage1-vs-Stage2 |
6.771800E-01 |
| Stage1-vs-Stage3 |
1.936210E-03 |
| Stage1-vs-Stage4 |
3.417200E-03 |
| Stage2-vs-Stage3 |
1.795180E-01 |
| Stage2-vs-Stage4 |
1.217570E-01 |
| Stage3-vs-Stage4 |
6.607000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.64600000000559E-05 |
| Normal-vs-AfricanAmerican |
1.646280E-02 |
| Normal-vs-Asian |
3.658900E-03 |
| Caucasian-vs-AfricanAmerican |
8.646200E-01 |
| Caucasian-vs-Asian |
8.509000E-01 |
| AfricanAmerican-vs-Asian |
9.789400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.72650000038888E-07 |
| Normal-vs-Female |
6.143600E-03 |
| Male-vs-Female |
3.136700E-03 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.552300E-02 |
| Normal-vs-Age(41-60Yrs) |
6.20390000000137E-05 |
| Normal-vs-Age(61-80Yrs) |
3.69759999999664E-05 |
| Normal-vs-Age(81-100Yrs) |
6.967900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.139600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.321700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.601600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.980600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.313800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.723400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.101100E-03 |
| Classical-VS-Follicular |
9.599200E-01 |
| Classical-VS-Other |
1.521370E-01 |
| Classical-VS-Normal |
1.982410E-03 |
| Tall-VS-Follicular |
4.914200E-02 |
| Tall-VS-Other |
6.774200E-01 |
| Tall-VS-Normal |
3.52319999999962E-05 |
| Follicular-VS-Other |
3.104800E-01 |
| Follicular-VS-Normal |
1.718330E-02 |
| Other-VS-Normal |
7.357700E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.647600E-04 |
| Normal-vs-N1 |
1.167110E-04 |
| N0-vs-N1 |
2.443200E-01 |
|
|
